deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT04760665

Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae (KAPEDIS)

Randomized, Superiority, Double Blind Controlled With Placebo, Clinical Trial, to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Klebsiella Pneumoniae Carbapenemase (KPC)-Producing

Sponsor: Maimónides Biomedical Research Institute of Córdoba

Updated 9 times since 2021 Last updated: Jul 8, 2024 Started: Oct 4, 2021 Primary completion: Nov 24, 2023 Completion: Nov 24, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of elegible population

A PHASE2 clinical study on Carbapenemase-producing Enterobacteriaceae Infection, this trial is terminated or withdrawn. The trial is conducted by Maimónides Biomedical Research Institute of Córdoba and has accumulated 9 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshotNot Yet Recruiting~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshotNot Yet Recruiting~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshotNot Yet Recruiting~Nov 2021 – ~Apr 2023 · 17 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotRecruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotRecruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Aug 2024 — Sep 2024 [monthly]

    Terminated PHASE2

    Status: RecruitingTerminated

  4. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE2

  5. Apr 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

Show 4 earlier versions
  1. Nov 2021 — Apr 2023 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  2. Oct 2021 — Nov 2021 [monthly]

    Not Yet Recruiting PHASE2

  3. Sep 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE2

  4. Mar 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maimónides Biomedical Research Institute of Córdoba
  • Mikrobiomik Healthcare Company S.L.
Data source: Maimónides Biomedical Research Institute of Córdoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations